Shenji Changhua
Shenji Changhua is a biotechnology company focusing on neurological diseases such as ALS.
Operating in biotechnology, health care, medical based in Asia-Pacific (APAC), Shenji Changhua was founded in 2021.
Within the biotechnology, health care, medical space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Asia-Pacific (APAC).
It is recorded at the Seed stage.
Its team size is recorded as c_00101_00250 employees.
Public records show total funding of about $120M.
| Sector | Biotechnology, Health Care, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00101_00250 |
| Stage | seed |
| Total funding | $120,000,000 |
Website: sineugene.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account